US 11072600
Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer
granted A61PA61P35/00
Quick answer
US patent 11072600 (Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer) held by The Regents of the University of California expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jul 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 42
- CPC classes
- A61P, A61P35/00